chrisvoncsefalvay/vaers-outcomes huggingface dataset:
It started with a funny sore throat on 6-14-2022. I was a little fatigued. I developed a cough during the night and I called the doctor the following morning. I tested on the 15th and it came back positive. The doctor prescribed PAXLOVID and I took that medication and within about 2 days I started to feel better. I currently feel that I have completely recovered from my symptoms.
Slight rash on left torso and under left arm within 90 minutes of 2nd vaccination.  Two hours later rash had spread to both torsos and both biceps. Friday the rash was complete from the top of my feet into my scalp, including inner thighs. Rash not in pubic area or on glutes. Rash was acting like hives with intense itching. At noon on Friday, my lips had swollen. My tongue did not swell. I had no difficulty breathing., no shortness of breath. Contacted Dr. via patient portal. Suggested protocol was colloidal oatmeal baths as needed, discontinue Valacyclovir, take second Aller Clear mid-day, and Benadryl at night. Protocol followed through the weekend, but by Tuesday, the itching was very intense. Made appointment to see Dr. on Thursday 2/25. He prescribed a six day course of Prednisone 10mg and taking hydroxyzine HCL 25mg 3 times daily to relieve itching.  By the second day (2/27) symptoms had abated. Colloidal baths  and anti-itch tablets discontinued. Finished Prednisone Rx.
pt recvd vax; chills & abdo cramps since 5am; bitten by bat on 15jun & recvd RIG & 1st dose; only came back on 21jun93 for 2nd dose (day 3);
Hives on arms, neck, face and abdomen starting at 3pm on 1/26/21.  No notable new inciting agents such as new medications, foods, soaps/detergents/lotions, or chemical exposures.
Loss of consciousness; single  syncopal episode; tried to get ready for work; did not sleep much that night; pain/body aches; Tired; Awoke nauseated; This case was received via VAERS on 27-Apr-2021 and was forwarded to Moderna on 27-Apr-2021.    This regulatory authority case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of LOSS OF CONSCIOUSNESS (Loss of consciousness) and SYNCOPE (single  syncopal episode) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Multiple organ dysfunction syndrome. Concurrent medical conditions included COPD and Asthma. Concomitant products included FLUTICASONE FUROATE, VILANTEROL TRIFENATATE (BREO ELLIPTA) and FLUTICASONE for an unknown indication.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced LOSS OF CONSCIOUSNESS (Loss of consciousness) (seriousness criterion medically significant), SYNCOPE (single  syncopal episode) (seriousness criterion medically significant), IMPAIRED WORK ABILITY (tried to get ready for work), INSOMNIA (did not sleep much that night), MYALGIA (pain/body aches), FATIGUE (Tired) and NAUSEA (Awoke nauseated ). At the time of the report, LOSS OF CONSCIOUSNESS (Loss of consciousness), SYNCOPE (single  syncopal episode), IMPAIRED WORK ABILITY (tried to get ready for work), INSOMNIA (did not sleep much that night), MYALGIA (pain/body aches), FATIGUE (Tired) and NAUSEA (Awoke nauseated ) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient has done a telehealth visit with physician  couple hours after the events.  No further treatment was rendered. Treatment information  was not provided.  Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. Patient's hx of multiple organ dysfunction syndrome is a confounding factor that may play a possible contributory role.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. Patient's hx of multiple organ dysfunction syndrome is a confounding factor that may play a possible contributory role.
01/16/22 presents to ED for "pain all over". PMHx of "legally blind, HTN, Cdiff, RA, HLD, HTN
flu; Initial information received on 17-Jan-2023 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-hcp.  This case involves an unknown age and unknown gender patient who experienced flu after receiving influenza vaccine.  The patient's past medical history, medical treatment(s), vaccination(s), concomitant disease or risk factor and family history were not provided.   On an unknown date, the patient received a dose of suspect Influenza Vaccine by unknown manufacturer (strength, formulation, dose, route, batch number and expiry date: unknown) in unknown administration site for prophylactic vaccination.  On an unknown date the patient developed flu (influenza) (unknown latency). It was reported that I got the vaccine but I just got over the flu.  Action taken :  not applicable.  It was not reported if the patient received a corrective treatment for the event (flu).  At time of reporting, the outcome was Unknown for the event flu.
I contracted COVID-19. My symptoms included coughing, congestion, and fatigue. I took over the counter MUCINEX medication. The first 7 days of contracting the virus was extremely rough for me. I am still dealing with the lingering cough, congestion, and fatigue. I was also prescribed PAXLOVID.
Swelling the size of a golf ball, rash at injection site down to elbow, extreme pain, even when not touching moving arm, nausea, hot flashes, sweating, cold chills, difficulty taking deep breathe
Patient c/o pain (throbbing) at injection site.  Turned pale, felt faint, tingling down left arm, developed nausea, BP checked 60/40 around 3:10pm.  Patient placed supine position, at 3:20pm BP 100/60 - 78.  Paramedics arrived PO 99%.  Informed us of history MVP (patient).  Patient ran this AM, drank approximately 2 glasses water and large cup coffee before coming to clinic for injection.  She received one cup water, after BP started to rise at 3:20pm.
Muscle soreness hrs. after administration. Soreness lasting still to present (8-18-11 at 5:30pm).
No further AE; temperature excursion involving multiple lot numbers for GARDASIL 9, MMR II, ROTATEQ, and RECOMBIV AX. Many of the vaccines have been administered to patients; This spontaneous report was received from a practice manager who was reporting on patient of unknown age and gender. There was no information about the patient's concurrent conditions, medical history, drug reactions or allergies and concomitant therapies provided.  On 05-AUG-2020, the patient was vaccinated with an improperly stored dose of Hepatitis B Vaccine (Recombinant) (RECOMBIVAX HB) lot number S008153 was confirmed to be valid, expiration date 31-OCT-2021 (dose, route and site of administration were not provided), for prophylaxis. On 04-AUG-2020, the administered dose of vaccine was stored in a temperature of 1.1 degrees Celsius for 27 hour and 45 minutes and at temperature of 9 degrees Celsius for 1 hour and 15 minutes. A digital data logger was involved. There were no previous excursions reported. There were no further adverse events reported.  This is one of several reports received from the same reporter. combinationproductreport: Yes; brandname: RECOMBIVAX HB SYRINGE (DEVICE); commondevicename: Hepatitis B Vaccine (Recombinant); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: S022583; expirationdate: 31-OCT-2021; deviceage and unit: 0; malfunction: Unknown; deviceusage: Initial; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability; Sender's Comments:  US-009507513-2010USA001083:
Pfizer 3/2, 3/23, and 9/24. Positive on 1/1/22
Pt received FLUVIRIN vaccine on 10/21/09. Minutes after she felt dizzy. PT developed hives, itchy skin. She felt like she was having an "out of body" experience. Reaction didn't start to dissipate til SAT 10/24/09. She reports past allergy to NEOMYCIN.
Diarrhea, Bell's palsy and drooling for 48-72 hours, extreme itchiness and heat left side, tingling left side, numbness left arm and face, nose
I got Cellulitis in my right leg, had the nurse at my job look at it. She told me that I needed to have it looked at, I went to Urgent Care after work. Was informed to go to the hospital to have an xray taken to make sure no blood clots. Went in and was found that I had infection going on they put me on Bactrim and Keflex. The next morning I was having an allergic reaction to the Bactrim, I followed up with my primary care doctor. I went in to see her that Friday and she wouldn't sub out the antibiotic said I didnt need it. Told me to follow up with her if I had any other reactions. Over the weekend ended up getting Cellulitis in my left leg with swelling and itching. When I followed up, she said it was probably not Cellulitis and probably Vascular that I needed to wear Compression Socks and Elevate my legs, that I needed to follow up with a Cardiologist as it was because I was borderline high blood pressure (which I have been for many years). I did that as I was informed and it ended up getting worse, I wasn't able to get into see a Cardiologist until the following Monday. My legs were getting worse after wearing Compression socks for two days in a row I had no choice but to go back to the hospital (where they informed me that it was definitely Cellulitis and gave me the opposite Antibiotic and a low dose of a water pill. A week later it got better.
Patient passed out for a few seconds 2-3 minutes after the vaccine. Complained of dizziness , sweating and unable to stand up. Patient's father, was with him at time of accident. His after caught him and prevented him from falling. Patient did not get hurt. Patient sat in front of vaccination room for about 20 minutes and left. I called to check on the patient the following morning at 9 AM and was told by patient father that patient is ok now.
3 Days of pain at injection site, fatigue, body ache, off and on fever, some shivers occasionally, intermittent nausea.
This spontaneous prospective pregnancy report as received from an approximately 27 year old female nurse practitioner refers to herself. The patient had no medical history and no known drug reactions or allergies. In either 2005 or 2006, the patient was vaccinated with the first dose of M-M-R II, (route, lot # and expiration date were not provided). In May 2013 and on 27-AUG-2013, the patient was vaccinated with the second and third doses of M-M-R II, 0.5 ml, subcutaneous  (lot # and expiration date were not provided). There were no concomitant medications. The patient reported that the reason she received the M-M-R II was due to her titers showed no immunity to measles. The patient stated that her titers were drawn on an unspecified date before her dose in May 2013 as well as again on an unspecified date before her dose on 27-AUG-2013. The patient became pregnant after receiving the second dose of M-M-R II, at the time of report, she was 4.5 weeks pregnant. On approximately 19-AUG-2013, the patient has her last menstrual period. No treatment was given to the patient. The patient did not seek medical attention. At the time of the report, the patient's status was unknown. Additional information has been requested.
24 hrs p/inject t102, swollen glands in neck, eye pain, generalized flu-like sx; took DPH & improved w/in 12 hrs;
Grapefruit sized red rash, burning pain at base of spinal cord (similar to shingles). Patient visited neurologist who recommended NOT to receive 2nd dose. Pain and burning lasted several days.
PT reported itching , sensation to throat but no swelling or trouble breath, I advised to stay longer since she reported similar symptoms with previous pfizer vaccine. Stayed until 2:45pm; was given by mouth benadryl at 2:05pm and by 2:45 pm was ok to go patient did not want EMS. Called pt later and left a voicemail to call back wanted to see how she was doing.
Expired Hiberix administered; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 6-month-old female patient who received Hib (Hiberix) (batch number 42EM3, expiry date 7th January 2023) for prophylaxis.   On 9th January 2023, the patient received the 3rd dose of Hiberix. On 9th January 2023, unknown after receiving Hiberix, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.       Additional Information: GSK receipt date: 11-JAN-2023 Reporters comment: The reporter reported that patient received the third dose of hiberix vaccine on 09-JAN-2023 which was expired on 07-JAN-2023. The Vaccine Administration Facility was the same as Primary Reporter The reporter consent to follow up Additional Supportive information: The reporter reported that patient received the third dose of hiberix which was expired which led to expired vaccine used.
Breathing trouble (acute asthma attacks, with regular nebulized meds and prednisone not helping); hospital administered IV of Benadryl, Pepcid, Steroid. Was told to take 50 mg prednisone for 5 days after hospital visit, along with Benadryl and Pepcid.
Initial report received on 09/Jan/2006 from a health care provider. A 25 year old male patient had received and administration (route not reported) of Menactra, lot number U1877AA, in the left deltoids; a subcutaneous injection of YF-VAX, lot number UE664AB, in the right arm; an administration (route not reported) of another manufacturer's Pneumococcal vaccine, lot number 1047P, in the left deltoid and an administration (route not reported) of another manufacturer's Hepatitis B vaccine, lot number 0031P, in the right deltoid on 06/Jan/2006 at 11:32. One day later, the patient developed a temperature of 103 degrees Fahrenheit and palpitations. On 09/Jan/2006 the patient's temperature was 98.4 degrees Fahrenheit and it was noted that the patient had a slightly red left arm that was also slight sore. It was not reported whether the patient had recovered from these events at the time of this report. Follow-up information received on 31/Jan/2006 from a health care provider. The event palpitations was a stress related anxiety syndrome. The size of the erythema is unknown. The reported arm pain occurred in the left arm. There were no relevant diagnostic tests performed. At the time of this report, the patient had recovered.
very very itchy; red and all over; hives; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (hives), PRURITUS (very very itchy) and ERYTHEMA (red and all over) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     Concurrent medical conditions included Hives (The day before vaccination,  01Feb2021, patient had eaten a cereal and had developed hives (patient said it was itchy but in a scale 1-10 it was a 2)) since 01-Feb-2021.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced URTICARIA (hives). On 02-Feb-2021, the patient experienced PRURITUS (very very itchy) and ERYTHEMA (red and all over). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) ongoing since an unknown date for Hives, at an unspecified dose and frequency and IBUPROFEN ongoing since an unknown date for Hives, at an unspecified dose and frequency. At the time of the report, URTICARIA (hives), PRURITUS (very very itchy) and ERYTHEMA (red and all over) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
patient was here on 1/16/21 for COVID Moderna vaccination.  Developed tingling of lips and scratchy throat 20 minutes after vaccine administered.  Seen by PA-C and Benadryl was administered.   Symptoms 10 minutes after Benadryl.  Patient left.   called patient on 1/17/21 and patient was feeling better, no other reactions/side effects.
pain; Headache; body aches; a little fever; This spontaneous case was reported by an other health care professional and describes the occurrence of PAIN (pain), HEADACHE (Headache), MYALGIA (body aches) and PYREXIA (a little fever) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B22A) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Pfizer vaccine on 27-Jan-2021, Pfizer vaccine on 17-Feb-2021 and Pfizer vaccine (1st booster) on 21-Nov-2021. Past adverse reactions to the above products included No adverse event with Pfizer vaccine, Pfizer vaccine and Pfizer vaccine.    On 06-Jul-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jul-2022, the patient experienced PAIN (pain), HEADACHE (Headache), MYALGIA (body aches) and PYREXIA (a little fever). At the time of the report, PAIN (pain), HEADACHE (Headache), MYALGIA (body aches) and PYREXIA (a little fever) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Treatment information was not provided. It was reported, patient experienced similar symptoms to what she experienced after the Pfizer vaccine. Concomitant product use was not provided by the reporter.
slimy cough/are wheezing and coughing a lot, specially at nigh; their voice is lower; are wheezing and coughing a lot, specially at nigh; head hurts when they cough; This spontaneous case was reported by a physician and describes the occurrence of COUGH (slimy cough/are wheezing and coughing a lot, specially at nigh), DYSPHONIA (their voice is lower), WHEEZING (are wheezing and coughing a lot, specially at nigh) and HEADACHE (head hurts when they cough) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027L20A and 027L21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included AMLODIPINE, ATORVASTATIN, ACETYLSALICYLIC ACID (BABY ASPIRIN) and ATORVASTATIN CALCIUM (LIPITOR) for an unknown indication.   On 06-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Mar-2021, the patient experienced COUGH (slimy cough/are wheezing and coughing a lot, specially at nigh), DYSPHONIA (their voice is lower), WHEEZING (are wheezing and coughing a lot, specially at nigh) and HEADACHE (head hurts when they cough). The patient was treated with GUAIFENESIN (MUCINEX) at an unspecified dose and frequency and BENZONATATE at a dose of 200 mg. At the time of the report, COUGH (slimy cough/are wheezing and coughing a lot, specially at nigh), DYSPHONIA (their voice is lower), WHEEZING (are wheezing and coughing a lot, specially at nigh) and HEADACHE (head hurts when they cough) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The treatment medication included Mucinex, Zyrtec, benzonatate and nasal rinse with a neti pot.   This case was linked to MOD21-052130 (Patient Link).
Child slept notably more for 2 days after shots and had complaints of headaches. Then on 7/29/01 cheeks of face and arms at injection site were noted reddened. Child felt warm to the touch, but thermometer registered no fever. On 8/2/01 rash had spread to chest, stomach, legs and child complained of chest pain and shortness of breath. Taken to ER and diagnosed as an allergic reaction to something. Given Rx for Claritin; mom states Claritin no effect; gave gild her medicin Hydroxyzide 25mg - effect results.
This spontaneous report as received from a nurse refers to an unspecified number of patients. On an unknown dare unspecified number of improperly stored doses of GARDASIL have been administered to patients. No adverse effects reported. This is one of several reports received from the same reporter. Additional information has been requested.
After injection, left arm was swollen, extremely sore for several days and movement was limited.  After about a week, it did not improve so I went to see my doctor.  She recommended physical therapy.  I went to PT once per week for about 5 weeks, and saw some improvement.  As of this date, no lingering side effects.  While at the health department receiving my first dose, my arm immediately went numb and I received EMS attention while there.  After being monitored for about 30 minutes, I was sent home.  Arm stayed numb for several days and eventually went away.
Information has been received from a Licensed Practical Nurse referring to an unspecified number of patients of unknown age and gender. There was no medical history or concurrent condition reported. On unspecified dates since 08-OCT-2015, the unspecified patients were vaccinated with doses of GARDASIL (lot # K023432, expiration date 18-JUN-2016, dosage, strength and route were not reported), which were exposed to temperatures outside of the recommended range. There was no concomitant medication reported. No adverse experience had been reported. This is one of several reports from the same reporter. Additional information has been requested.
This spontaneous report as received from an other health professional refers to unspecified number of patients unknown age and gender. On unknown dates, the patients were vaccinated with VAQTA lot # M036458 with expiration date 02-MAR-2018 and lot # M006458 (determined to be not valid) with expiration date 18-AUG-2017. On an unknown date, the patient experienced incorrect product storage and no adverse event. Additional information has been requested. Sender's Comments: US-009507513-1708USA012331: US-009507513-1708USA012441
Mother reports pt. c/o fever, headache onset 7 PM 4/10/12. Treated with ADVIL 4 tsp. 4.11.12 AM continues to c/o lethargy, nausea, fever 100.2 - to take ADVIL 4 tsp at 1330. 4/11/12 430 PM - spoke to pt. - reports improv. of symptoms.